Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum-Reference-Cited by-同舟云学术

Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum

Published:2021-10-20 Issue:4 Volume:2 Page:765-773
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Nakaya Aya¹²^ORCID,Shibayama Hirohiko³²,Nakatani Eiji⁴²,Shimura Yuji⁵²^ORCID,Kosugi Satoru⁶²,Tanaka Hirokazu⁷²,Fuchida Shin‐Ichi⁸²^ORCID,Kanda Junya⁹²^ORCID,Uoshima Nobuhiko¹⁰²,Kaneko Hitomi¹¹²,Imada Kazunori¹¹²,Ohta Kensuke¹²²,Ito Tomoki¹²,Yagi Hideo¹³²,Yoshihara Satoshi¹⁴²^ORCID,Hino Masayuki¹⁵²,Shimazaki Chihiro⁸²,Takaori‐Kondo Akifumi⁹²,Kuroda Junya⁵²^ORCID,Matsumura Itaru⁷²,Kanakura Yuzuru¹⁶²,Nomura Shosaku¹²

Affiliation:

1. First Department of Internal Medicine Kansai Medical University Osaka Japan

2. Kansai Myeloma Forum Osaka Japan

3. Department of Hematology and Oncology University Graduate School of Medicine Osaka Japan

4. Graduate School of Public Health Shizuoka Graduate University of Public Health Shizuoka Japan

5. Division of Hematology and Oncology, Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan

6. Department of Internal Medicine (Hematology) Toyonaka Municipal Hospital Osaka Japan

7. Department of Hematology and Rheumatology Kindai University Faculty of Medicine Osaka Japan

8. Department of Hematology Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center Kyoto Japan

9. Department of Hematology and Oncology, Graduate School of Medicine Kyoto University Kyoto Japan

10. Department of Hematology Japanese Red Cross Kyoto Daini Hospital Kyoto Japan

11. Department of Hematology Japanese Red Cross Osaka Hospital Osaka Japan

12. Hematology Ohta Clinic Shinsaibashi Osaka Japan

13. Department of Hematology and Oncology Nara Prefecture General Medical Center Nara Japan

14. Division of Hematology, Department of Internal Medicine Hyogo College of Medicine Hyogo Japan

15. Department of Hematology Osaka City University Graduate School of Medicine Osaka Japan

16. Department of Hematology Sumitomo Hospital Osaka Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.284

Reference20 articles.

1. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

2. Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

3. Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

4. A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

5. The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis